RWJBarnabas Health said Sept. 16 that it recently announced a series of systemwide leadership and management transitions, and expanded responsibilities for seven key executives, elevating them to executive vice president titles.
The health care system said these senior team members have been promoted to recognize both the importance of their position as well as the tremendous contributions they have made as individuals to the success of the organization.
Ostrowsky
“To further build upon our current success, we must continually assess how we are structured and ensure we have the best leadership in every role. These executives have demonstrated an outstanding commitment to our mission of delivering world-class patient care to communities across the state of New Jersey,” said Barry Ostrowsky, president and chief executive officer, RWJBarnabas Health. “I am proud of their accomplishments and eager to move forward with this team of diverse leaders who are each dedicated to excellence in their respective fields. I am equally pleased to further our commitment to equity and diversity, as we continue to elevate the roles and responsibilities associated with this very important part of our mission.”
Executive leadership elevations
Dr. Paul Alexander assumed the role of executive vice president, chief equity and transformation officer. His role encompasses accountable care organization management, the employee health plan, and other resources dedicated to building necessary infrastructure. He will also oversee RWJBarnabas Health’s Social Impact and Community Investment (SICI) practice.
Holecek
Nancy Holecek assumed the role of executive vice president, chief nursing officer. Holecek oversees over 11,000 nursing professionals and leads the system’s nursing initiatives in strategic planning, fiscal decisions, patient satisfaction, care coordination and quality.
Gail Kosyla assumed the role of executive vice president, system financial operations. In this role, she is responsible for the financial functions supporting the medical group, as well as treasury operations.
Lew
Dr. Indu Lew, a 2020 NJBIZ Best 50 Women in Business honoree, assumed the role of executive vice president, chief pharmacy officer. She manages the pharmaceutical supply chain, ensures quality outcomes through performance improvement activities, and works to optimize the overall pharmacy and patient care environments.
DeAnna Minus-Vincent assumed the role of executive vice president, chief social justice and accountability officer. In this role, she will primarily focus on the importance of advancing the Ending Racism Together initiative, for both the institution and surrounding communities.
Dr. Trina Parks assumed the role of executive vice president, chief corporate diversity and inclusion officer. This role supports the successful work of the Corporate Office of Diversity and Inclusion (CODI), focused on attracting and developing diverse talent, and engaging respectfully with RWJBarnabas Health’s diverse communities.
Eileen Urban was formerly the chief investment officer and senior vice president of treasury. Earlier this year, RWJBarnabas Health announced Urban’s retirement. In recognition of her vast contributions to the system—including establishing a world-class investment management and treasury function, exceptional management of the system’s $2.5 billion debt portfolio and serving as a mentor to countless system leaders—Urban was named executive vice president, treasury, and chief investment officer.
